Latest News and Press Releases

Subversive Acquisition LP Has Met All Conditions of Closing and Expects to Close on or Before Friday April 23, 2021 SPAC Restricted Voting Units Currently Trade on the TSX Under the Symbol “SVX.U”...

TORONTO, April 10, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that closing of its qualifying transaction to combine with...

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that the date by which SVX has to consummate its qualifying...

TORONTO, April 06, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U NEO: SVX.U OTCQX: SBVRF) (“SVX”) announced today that that its unitholders have overwhelmingly approved its...

TORONTO, April 06, 2021 (GLOBE NEWSWIRE) -- SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”),...

InterCure Signs Letter of Intent with Cann Pharmaceutical Ltd. Acquisition Strengthens InterCure’s Position as the Largest Cannabis Company Outside of North America TORONTO, April 05, 2021 ...

InterCure to expand its operations into Austria and Luxembourg Medicann, InterCure’s JV Partner, has committed a €10 million investment into InterCure's Austrian subsidiary Transaction approved by...

InterCure, dba Canndoc, Announces Record-Breaking Q4 Results with Positive EBITDA and Cash Flow InterCure Acquires Four New Medical Cannabis Pharmacies and Increases 2021 Target to 10 Retail...

LOD, Israel, Oct. 7, 2008 (GLOBE NEWSWIRE) -- InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE:INCR), today announced that Circulation: Heart Failure, a...